These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 667439)

  • 1. Tumour growth and response to treatment: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen [proceedings].
    Bennett A; Houghton J; Leaper DJ; Stamford IF
    Br J Pharmacol; 1978 Jun; 63(2):356P-357P. PubMed ID: 667439
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of flurbiprofen and 16,16-dimethyl-prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats. I. Squamous epithelium and mesenchymal tissue.
    Lehnert T; Deschner EE; Karmali RA; DeCosse JJ
    J Natl Cancer Inst; 1987 May; 78(5):923-9. PubMed ID: 3472001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of adrenergic adaptation in the eye with a prostaglandin synthesis inhibitor.
    Duffin RM; Christensen RE; Bergamini MV
    Invest Ophthalmol Vis Sci; 1981 Nov; 21(5):756-9. PubMed ID: 7298279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flurbiprofen and 16,16-dimethyl prostaglandin E2 on gastrointestinal tumorigenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats: glandular epithelium of stomach and duodenum.
    Lehnert T; Deschner EE; Karmali RA; DeCosse JJ
    Cancer Res; 1990 Jan; 50(2):381-4. PubMed ID: 2295078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin shock in the pig: release of prostaglandins and beneficial effects of flurbiprofen.
    Schrauwen E; Vandeplassche G; Laekeman G; Houvenaghel A
    Arch Int Pharmacodyn Ther; 1983 Apr; 262(2):332-4. PubMed ID: 6409020
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal prostaglandins and calcium excretion in urolithiasis.
    Buck AC
    J Int Med Res; 1983; 11 Suppl 2():18-23. PubMed ID: 6347754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of flurbiprofen on the responses to frusemide in healthy volunteers.
    Symmons DP; Kendall MJ; Rees JA; Hind ID
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):350-4. PubMed ID: 6885206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of chronic aspirin treatment to inhibit urinary prostaglandin excretion in spontaneously hypertensive rats: comparison with indomethacin and flurbiprofen.
    Quilley CP; McGiff JC; Quilley J
    J Pharmacol Exp Ther; 1987 Mar; 240(3):916-21. PubMed ID: 3559984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.
    Bennett A; Houghton J; Leaper DJ; Stamford IF
    Prostaglandins; 1979 Feb; 17(2):179-91. PubMed ID: 441430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of measurable changes in effective renal plasma flow and glomerular filtration rate in conscious rats after prostaglandin synthetase inhibition by indomethacin or flurbiprofen [proceedings].
    Haylor J; Lote CJ
    J Physiol; 1979 Oct; 295():105P-106P. PubMed ID: 521913
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the protection against misonidazole-induced toxicity by antiinflammatory agents.
    Millar BC; Chaplin DJ; Jinks S
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():303-8. PubMed ID: 6221607
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of flurbiprofen and aspirin in soft tissue trauma.
    Muckle DS
    Br J Sports Med; 1976 Mar; 10(1):11-3. PubMed ID: 786422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostaglandin synthesis and leucocyte migration by flurbiprofen.
    Adams SS; Burrows CA; Skeldon N; Yates DB
    Curr Med Res Opin; 1977; 5(1):11-6. PubMed ID: 410589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of flurbiprofen on the platelet function in patients with ischemic cardiopathy].
    Davì G; Riolo FP; Novo S; Custro N; Avellone G; Mattina A; Strano A
    Cardiologia; 1982 Oct; 27(10):953-61. PubMed ID: 6892383
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of flurbiprofen to inhibit corneal neovascularization.
    Cooper CA; Bergamini MV; Leopold IH
    Arch Ophthalmol; 1980 Jun; 98(6):1102-5. PubMed ID: 6155898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester].
    Wallace JL; Muscará MN; de Nucci G; Zamuner S; Cirino G; del Soldato P; Ongini E
    J Pharmacol Exp Ther; 2004 May; 309(2):626-33. PubMed ID: 14755007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical flurbiprofen or prednisolone. Effect on corneal wound healing in rabbits.
    Miller D; Gruenberg P; Miller R; Bergamini MV
    Arch Ophthalmol; 1981 Apr; 99(4):681-2. PubMed ID: 7224940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
    Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
    Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flurbiprofen and thyroid function tests.
    Cremoncini CM; Libroia A; Valente C; Cremoncini A; Della Croce F; Losa M; Lerro S; Franco PA; Longoni A
    Br J Clin Pract; 1984; 38(11-12):399-402. PubMed ID: 6397221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.